share_log

Invitae Analyst Ratings

Invitae Analyst Ratings

邀請分析師評級
Benzinga ·  2023/10/20 09:43
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
10/20/2023 -15.4% Goldman Sachs $1 → $0.5 Maintains Sell
08/15/2023 -15.4% Piper Sandler $1.5 → $0.5 Maintains Underweight
07/24/2023 69.2% Goldman Sachs $1.5 → $1 Maintains Sell
07/21/2023 69.2% Goldman Sachs $1.5 → $1 Maintains Sell
05/15/2023 — Raymond James Downgrades Market Perform → Underperform
05/11/2023 153.81% Goldman Sachs $2 → $1.5 Maintains Sell
03/03/2023 196.11% Piper Sandler $2.25 → $1.75 Maintains Underweight
01/31/2023 238.41% Goldman Sachs → $2 Downgrades Neutral → Sell
11/09/2022 407.61% SVB Leerink $2.5 → $3 Maintains Market Perform
08/25/2022 69.2% Credit Suisse → $1 Initiates Coverage On → Underperform
08/18/2022 280.71% Piper Sandler $2.5 → $2.25 Maintains Underweight
08/10/2022 — JP Morgan Downgrades Neutral → Underweight
08/10/2022 323.01% SVB Leerink $2 → $2.5 Maintains Market Perform
07/26/2022 323.01% Cowen & Co. $8 → $2.5 Downgrades Outperform → Market Perform
07/21/2022 — Raymond James Downgrades Outperform → Market Perform
07/19/2022 1253.64% Cowen & Co. $10 → $8 Maintains Outperform
07/19/2022 — Benchmark Downgrades Buy → Hold
07/19/2022 238.41% SVB Leerink $8 → $2 Downgrades Outperform → Market Perform
06/13/2022 915.23% Benchmark $13 → $6 Maintains Buy
06/03/2022 323.01% Piper Sandler → $2.5 Initiates Coverage On → Underweight
05/05/2022 1338.24% Raymond James $10.5 → $8.5 Maintains Outperform
05/04/2022 2776.48% Morgan Stanley $18 → $17 Maintains Equal-Weight
04/19/2022 1592.05% Goldman Sachs $14 → $10 Maintains Neutral
04/18/2022 1676.65% Raymond James $15 → $10.5 Maintains Outperform
02/28/2022 2438.07% Raymond James $36 → $15 Maintains Outperform
02/25/2022 4130.12% SVB Leerink $30 → $25 Maintains Outperform
02/15/2022 2945.69% Morgan Stanley $37 → $18 Maintains Equal-Weight
11/09/2021 5991.37% Raymond James $38 → $36 Maintains Outperform
08/05/2021 6668.19% Morgan Stanley $41 → $40 Maintains Equal-Weight
08/04/2021 5822.17% Benchmark → $35 Upgrades Hold → Buy
06/21/2021 5822.17% Wells Fargo $30 → $35 Maintains Equal-Weight
06/15/2021 6160.58% Raymond James → $37 Initiates Coverage On → Outperform
06/03/2021 5483.76% Goldman Sachs → $33 Initiates Coverage On → Neutral
05/25/2021 4976.14% Wells Fargo → $30 Initiates Coverage On → Equal-Weight
05/06/2021 6837.39% Morgan Stanley $45 → $41 Maintains Equal-Weight
05/05/2021 8360.24% SVB Leerink $65 → $50 Maintains Outperform
04/05/2021 8021.83% Oppenheimer → $48 Upgrades Perform → Outperform
02/22/2021 7514.21% Morgan Stanley $41 → $45 Maintains Equal-Weight
02/19/2021 7514.21% Morgan Stanley $41 → $45 Maintains Equal-Weight
02/18/2021 9713.87% Ladenburg Thalmann $46.5 → $58 Upgrades Neutral → Buy
02/18/2021 10898.31% SVB Leerink $64 → $65 Maintains Outperform
02/01/2021 — Oppenheimer Downgrades Outperform → Perform
01/20/2021 10729.1% SVB Leerink $48 → $64 Maintains Outperform
11/06/2020 6837.39% Morgan Stanley $38 → $41 Maintains Equal-Weight
11/06/2020 8021.83% SVB Leerink $44 → $48 Maintains Outperform
11/03/2020 7345.01% SVB Leerink $34 → $44 Maintains Outperform
10/14/2020 7514.21% JP Morgan → $45 Downgrades Overweight → Neutral
09/09/2020 6329.78% Morgan Stanley → $38 Initiates Coverage On → Equal-Weight
08/05/2020 5652.96% SVB Leerink $40 → $34 Maintains Outperform
07/15/2020 6668.19% SVB Leerink $25 → $40 Maintains Outperform
07/01/2020 — Benchmark Downgrades Buy → Hold
05/06/2020 4130.12% SVB Leerink $20 → $25 Maintains Outperform
04/08/2020 3284.09% Benchmark $31 → $20 Maintains Buy
03/04/2019 — Chardan Capital Initiates Coverage On → Buy
日期 上行/下行 分析公司 目標價格變化 評級變化 上一次/當前評級
10/20/2023 -15.4% 高盛 $1→$0.5 維護 賣
2023年08月15日 -15.4% 派珀·桑德勒 $1.5→$0.5 維護 體重不足
07/24/2023 69.2% 高盛 $1.5→$1 維護 賣
07/21/2023 69.2% 高盛 $1.5→$1 維護 賣
2023年05月15日 - 雷蒙德·詹姆斯 評級下調 市場表現→表現不佳
2023年05月11日 153.81% 高盛 $2→$1.5 維護 賣
03/03/2023 196.11% 派珀·桑德勒 $2.25→$1.75 維護 體重不足
2023年年1月31日 238.41% 高盛 →$2 評級下調 中性→銷售
11/09/2022 407.61% SVB Leerink $2.5→$3 維護 市場表現
2022年08月25日 69.2% 瑞士信貸 →$1 開始承保 →表現不佳
2022/08/18 280.71% 派珀·桑德勒 $2.5→$2.25 維護 體重不足
2022年08月10日 - 摩根大通 評級下調 中性→減持
2022年08月10日 323.01% SVB Leerink $2→$2.5 維護 市場表現
07/26/2022 323.01% 考恩公司 $8→$2.5 評級下調 跑贏→市場表現
07/21/2022 - 雷蒙德·詹姆斯 評級下調 跑贏→市場表現
07/19/2022 1253.64% 考恩公司 $10→$8 維護 跑贏大盤
07/19/2022 - 基準 評級下調 購買→Hold
07/19/2022 238.41% SVB Leerink $8→$2 評級下調 跑贏→市場表現
2022/06/13 915.23% 基準 $13→$6 維護 買
06/03/2022 323.01% 派珀·桑德勒 →$2.5 開始承保 →減持
05/05/2022 1338.24% 雷蒙德·詹姆斯 $10.5→$8.5 維護 跑贏大盤
05/04/2022 2776.48% 摩根士丹利 $18→$17 維護 等重
04/19/2022 1592.05% 高盛 $14→$10 維護 中性
04/18/2022 1676.65% 雷蒙德·詹姆斯 $15→$10.5 維護 跑贏大盤
02/28/2022 2438.07% 雷蒙德·詹姆斯 $36→$15 維護 跑贏大盤
02/25/2022 4130.12% SVB Leerink $30→$25 維護 跑贏大盤
02/15/2022 2945.69% 摩根士丹利 $37→$18 維護 等重
11/09/2021 5991.37% 雷蒙德·詹姆斯 $38→$36 維護 跑贏大盤
08/05/2021 6668.19% 摩根士丹利 $41→$40 維護 等重
08/04/2021 5822.17% 基準 →$35 升級 持有→購買
2021/06/21 5822.17% 富國銀行 $30→$35 維護 等重
2021/06/15 6160.58% 雷蒙德·詹姆斯 →$37 開始承保 →跑贏大盤
06/03/2021 5483.76% 高盛 →$33 開始承保 →中性
2021/05/25 4976.14% 富國銀行 →$30 開始承保 →等重
05/06/2021 6837.39% 摩根士丹利 $45→$41 維護 等重
05/05/2021 8360.24% SVB Leerink $65→$50 維護 跑贏大盤
04/05/2021 8021.83% 奧本海默 →$48 升級 →表現強於大盤
02/22/2021 7514.21% 摩根士丹利 $41→$45 維護 等重
02/19/2021 7514.21% 摩根士丹利 $41→$45 維護 等重
02/18/2021 9713.87% 拉登堡·塔爾曼 $46.5→$58 升級 中性→購買
02/18/2021 10898.31% SVB Leerink $64→$65 維護 跑贏大盤
02/01/2021 - 奧本海默 評級下調 超越→表現
01/20/2021 10729.1% SVB Leerink $48→$64 維護 跑贏大盤
11/06/2020 6837.39% 摩根士丹利 $38→$41 維護 等重
11/06/2020 8021.83% SVB Leerink $44→$48 維護 跑贏大盤
11/03/2020 7345.01% SVB Leerink $34→$44 維護 跑贏大盤
10/14/2020 7514.21% 摩根大通 →$45 評級下調 超重→中性
09/09/2020 6329.78% 摩根士丹利 →$38 開始承保 →等重
08/05/2020 5652.96% SVB Leerink $40→$34 維護 跑贏大盤
07/15/2020 6668.19% SVB Leerink $25→$40 維護 跑贏大盤
07/01/2020 - 基準 評級下調 購買→Hold
05/06/2020 4130.12% SVB Leerink $20→$25 維護 跑贏大盤
04/08/2020 3284.09% 基準 $31→$20 維護 買
2019/03/04 - 查爾丹資本 開始承保 →購買

What is the target price for Invitae (NVTA)?

Invitae(NVTA)的目標價是多少？

The latest price target for Invitae (NYSE: NVTA) was reported by Goldman Sachs on October 20, 2023. The analyst firm set a price target for $0.50 expecting NVTA to fall to within 12 months (a possible -15.40% downside). 9 analyst firms have reported ratings in the last year.

高盛於2023年10月20日報告了Invitae(紐約證券交易所代碼：NVTA)的最新目標價。這家分析公司將NVTA的目標價設定為0.50美元，預計NVTA將在12個月內跌至(可能下跌15.40%)。去年有9家分析公司公佈了評級。

What is the most recent analyst rating for Invitae (NVTA)?

Invitae(NVTA)的最新分析師評級是多少？

The latest analyst rating for Invitae (NYSE: NVTA) was provided by Goldman Sachs, and Invitae maintained their sell rating.

對Invitae(紐約證券交易所代碼：NVTA)的最新分析師評級由高盛提供，Invitae維持其賣出評級。

When is the next analyst rating going to be posted or updated for Invitae (NVTA)?

Invitae(NVTA)的下一次分析師評級將於何時發佈或更新？

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Invitae, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Invitae was filed on October 20, 2023 so you should expect the next rating to be made available sometime around October 20, 2024.

分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Invitae的高管和客戶交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Invitae的上一次評級是在2023年10月20日提交的，所以你應該預計下一次評級將在2024年10月20日左右的某個時候公佈。

Is the Analyst Rating Invitae (NVTA) correct?

分析師評級邀請函(NVTA)正確嗎？

While ratings are subjective and will change, the latest Invitae (NVTA) rating was a maintained with a price target of $1.00 to $0.50. The current price Invitae (NVTA) is trading at is $0.59, which is out of the analyst's predicted range.

雖然評級是主觀的，並將發生變化，但最新的Invitae(NVTA)評級維持不變，目標價在1.00美元至0.50美元之間。目前Invitae(NVTA)的交易價格為0.59美元，超出了分析師的預測區間。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論